MicroSynbiotiX

Microalgae synthetic biology company: A platform for oral delivery of vaccines to animals

Company Details

Aquaculture is the future of sustainable food production. It is the world’s fastest growing food sector, with an estimated worth of 200 billion USD, but every year, farmers face a crisis with managing disease, losing more than 10 billion USD worth of fish stocks annually. MicroSynbiotiX is developing cost-effective oral vaccines to combat these infections and improve global food security. We are developing a novel, patent-pending method of producing oral vaccines using transgenic microalgae. Our solution will make disease management much more sustainable and reduce the need for antibiotics.

  • MicroSynbiotiX- oral drug delivery technology

Company People

Simon Jegan

Simon Jegan
CEO & Co-Founder

Antonio Lamb

Antonio Lamb
COO & Co-Founder

MicroSynbiotiX News

VIEW ALL

GET IN TOUCH WITH MicroSynbiotiX

Please tell us a little bit about yourself and why you'd like to get connected.

MicroSynbiotiX + SOSV will follow up with you via email.

** If you are interested in investing directly into SOSV's portfolio of privately held companies, or into SOSV's funds, you need to meet the SEC’s criteria for accredited investor status. As an individual, you can qualify as an accredited investor by either (a) having more than $200,000 in annual income for each of the past two years (or $300,000 with your spouse) and a reasonable expectation of earning the same this year or (b) having a net worth of at least $1 million (not including your principal residence). Learn More

You might also be interested in

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.